Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Interleukin-2 × 30 days × Clear all

Sponsor

Conditions

Recurrence 2 Ovarian Neoplasms 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 26 Cisplatin 21 Cetuximab 19 Carboplatin 18 Magnetic Resonance Spectroscopy 12 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Paclitaxel 8 Radiotherapy 7 Platinum 7 Nivolumab 7 Fluorouracil 7 Docetaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 5 Ipilimumab 4 atezolizumab 3 Taxes 3 Radiosurgery 3 Immunoglobulin G 3 Fulvestrant 3 Drug Therapy 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 dehydroftorafur 2 cemiplimab 2 Surgical Procedures, Operative 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡